NCT07067775View on ClinicalTrials.gov

Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 5, 2025

Primary Completion Date

August 22, 2025

Study Completion Date

August 22, 2025

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Vicagrel Capsules

Vicagrel Capsules qd per period, for two periods

DRUG

Clopidogrel Tablets

Clopidogrel Tablets qd per period, for two periods

Trial Locations (1)

Unknown

The First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY